arrow
A

Austin Larson

University of Colorado System
H指数:26
被引数:2,582

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

L-fucose supplementation in a patient with global hypofucosylation and a mono-allelic variant in SLC35C1: Clinical improvement and assessment of biomarkers

L-岩藻糖补充治疗全球岩藻糖基化降低及SLC35C1单等位基因变异患者的临床改善与生物标志物评估

2026-01-010
PRE
Signs, symptoms, and health-related quality of life in MELAS: measuring what's important from the patient and clinician perspectives
2025-10-270
OA
ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis
2024-09-010
PRE
Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort
2024-08-017
PRE
A complement C4-derived glycopeptide is a biomarker for PMM2-CDG

补体C4-derived糖肽是PMM2-CDG的生物标志物

2024-04-081
OA
Evaluation of chenodeoxycholic acid treatment in adult patients with cerebrotendinous xanthomatosis: A randomized, placebocontrolled Phase 3 study (RESTORE)

评估鹅去氧胆酸治疗成年脑腱黄瘤病患者: 一项随机,安慰剂对照的3期研究 (RESTORE)

2024-04-011
PRE
Tracer metabolomics reveals the role of aldose reductase in glycosylation

示踪代谢组学揭示醛糖还原酶在糖基化中的作用

2023-06-0110
OAAI
Loss of FOCAD, operating via the SKI messenger RNA surveillance pathway, causes a pediatric syndrome with liver cirrhosis
2022-07-219
OA